Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human CD227/MUC1 Antibody (SAA0075)

Catalog #:   FHD14220 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: FCM
Accession: P15941
Overview

Catalog No.

FHD14220

Species reactivity

Human

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Conjugation

Unconjugated

Target

PEMT, CA 15-3, H23AG, Peanut-reactive urinary mucin, PEM, EMA, Cancer antigen 15-3, MUC-1, Episialin, MUC1-CT, MUC1-beta, Tumor-associated mucin, CD227, Polymorphic epithelial mucin, KL-6, MUC1-alpha, MUC1, PUM, Krebs von den Lungen-6, MUC1-NT, Tumor-associated epithelial membrane antigen, Mucin-1, Breast carcinoma-associated antigen DF3, Carcinoma-associated mucin

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P15941

Applications

FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA0075

Data Image
References

Using Ru-PdO@MXenes-Nanostructured Electrochemical Immunosensing System for Selective Detection of Multiple Breast Biomarkers (HER2 and MUC1)., PMID:40489703

Balancing Antigen Loading on Gold Nanoparticles: Implications for Future Cancer Vaccine Strategies., PMID:40448390

Effective CAR T-cell targeting of an MUC1 cleavage product., PMID:40447312

Enhancing Cancer Vaccine Efficacy: Backbone Modification with β‑Amino Acids Alters the Stability and Immunogenicity of MUC1-Derived Glycopeptide Formulations., PMID:40443897

Harnessing MUC1 aptamer-targeted nanoparticles for precision medicine in breast cancer., PMID:40360093

The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma., PMID:40358156

Breast Implants Elicit Local and Systemic Immune Response: Evidence for Breast Cancer Immunosurveillance., PMID:40294644

C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences., PMID:40284463

GMMA decorated with mucin 1 Tn/STn mimetics elicit specific antibodies response and inhibit tumor growth., PMID:40234452

Structure of the Fab fragment of a humanized 5E5 antibody to a cancer-specific Tn-MUC1 epitope., PMID:40221891

Pulse corticosteroid therapy in interstitial lung disease-associated with anti-aminoacyl-tRNA synthetase antibodies: Comparable efficacy with potential for reduced adverse events., PMID:40158665

Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assay., PMID:40148706

Study on the Construction and Anti-Tumor Effect of aPDL1/aMUC1 Double Antibody Modification of Doxorubicin Liposome., PMID:40124041

Immunofluorescent analysis of exosomes using a microchip filled with transparent antibody-conjugated beads for breast cancer liquid biopsy., PMID:40015783

Magnetic Cell Separation Based on Protein Nanoparticles Mediating the Interaction between Magnetic Particles and Target Cells., PMID:39910821

Chemoenzymatic liquid-phase synthesis and immunogenic assessment of tumor-associated complex MUC1 glycopeptide variants., PMID:39892541

MUC1 and glycan probing of CA19-9 captured biomarkers from cyst fluids and serum provides enhanced recognition of ovarian cancer., PMID:39863644

CCL4 Affects Eosinophil Survival via the Shedding of the MUC1 N-Terminal Domain in Airway Inflammation., PMID:39791734

Highly efficient electrochemical biosensing platform in breast cancer detection based on MOF-COF@Au core-shell like nanostructure., PMID:39617770

Clinical characteristics and prognostic factors for MPO-ANCA positive interstitial lung disease: A comparative study of ANCA associated vasculitis (AAV)-ILD and pulmonary limited vasculitis., PMID:39580874

Ultrasensitive ECL immunoassay for CA15-3 via self-enhanced L012-loaded ZnNi-MOF as an emitter and CeO2-Pt as a co-reaction accelerator., PMID:39489068

Terminal deoxynucleotidyl transferase (TdT) based template-free signal amplification for the detection of exosomes in MUC1-positive cells., PMID:39454542

Cohort study of serological biomarkers for interstitial lung disease in patients with rheumatoid arthritis., PMID:39450495

Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention., PMID:39450169

Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions., PMID:39449327

Risk prediction modelling in idiopathic inflammatory myositis-associated interstitial lung disease based on seven factors including serum KL-6 and lung ultrasound B-lines., PMID:39360376

Carbon Nitride Nanosheets as an Adhesive Layer for Stable Growth of Vertically-Ordered Mesoporous Silica Film on a Glassy Carbon Electrode and Their Application for CA15-3 Immunosensor., PMID:39339328

Discovery of a fully human antibody to the proximal membrane terminus of MUC1 based on a B-cell high-throughput screening technique., PMID:39317052

VEGF165b mutant can be used as a protein carrier to form a chimeric tumor vaccine with Mucin1 peptide to elicit an anti-tumor response., PMID:39298996

Non-Natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity., PMID:39275921

Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer., PMID:39154820

A novel immunofluorescence study of Lingual Salivary Glands in the Egyptian Tortoise (Testudo kleinmanni) and its ecological significance., PMID:39137537

Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy., PMID:39105847

Characterization of human tibrovirus envelope glycoproteins., PMID:38953631

Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probes., PMID:38935849

Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine., PMID:38910324

Comparative analysis of renal decline rates in microscopic polyangiitis: unveiling the slowly progressive phenotype., PMID:38907617

Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants., PMID:38864844

Realization of high-performance biosensor through sandwich analysis utilizing weak value amplification., PMID:38830277

Enhanced synthesis of antibody-functionalized gold nanoparticles for multiplexed exosome detection via mass signal amplification in LDI-TOF MS., PMID:38780862

Versatile Metal-Organic Framework Incorporating Ag2S for Constructing a Photoelectrochemical Immunosensor for Two Breast Cancer Markers., PMID:38757510

Protocol to prepare MUC1 glycopeptide vaccines and evaluate immunization effects in mice., PMID:38691463

Target-induced DNA nanomachine operation for the detection of proteins., PMID:38669960

Unlocking PD-1 antibody resistance: The MUC1 DNA vaccine augments CD8+ T cell infiltration and attenuates tumour suppression., PMID:38605549

Spectrally separated dual-label upconversion luminescence lateral flow assay for cancer-specific STn-glycosylation in CA125 and CA15-3., PMID:38584178

Reverse-engineering the anti-MUC1 antibody 139H2 by mass spectrometry-based de novo sequencing., PMID:38508723

Distinguishing two distinct types of salivary extracellular vesicles: a potential tool for understanding their pathophysiological roles., PMID:38481961

Molecular Dynamics Simulation and Docking of MUC1 O-Glycopeptide., PMID:38347427

Solution NMR Analysis of O-Glycopeptide-Antibody Interaction., PMID:38347421

Differential Glycoform Analysis of MUC1 Derived from Biological Specimens Using an Antibody-Overlay Lectin Microarray., PMID:38347414

Datasheet
$ 225
Product specifications
50 μg 225 100 μg 372

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CD227/MUC1 Antibody (SAA0075) [FHD14220]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only